Saturday, January 31, 2015

House Committee Unveils Drug Development Incentives, FDA Regulatory Overhaul

House Committee Unveils Drug Development Incentives, FDA Regulatory Overhaul

The House Energy & Commerce Committee that oversees the FDA is planning an overhaul of agency procedures to increase orphan drug development, streamline clinical trials oversight, give industry incentives to find new uses for old drugs and expand U.S. drug manufacturing. Read More

Poor Validation of APIs Result in 483 for Manufacturer

Poor Validation of APIs Result in 483 for Manufacturer

A Japanese active pharmaceutical ingredient manufacturer received a Form 483 for poor validation of its manufacturing methods and supplier controls. Read More

Educational Conference 2015-IACP

  1. Educational Conference 2015 - International Academy of ...

    www.iacprx.org/?page=12
    6 days ago - The American College of Apothecaries (ACA), the International Academy ofCompounding Pharmacists (IACP) and the American College of Veterinary ...

January 26, 2015 FTC Proposes Amendments to Fair Packaging and Labeling Act Rules

If your company sells consumer products, you’ll want to take a look at the Federal Trade Commission’s (FTC’s) proposed amendments to its Fair Packaging and Labeling Act (FPLA)rules announced on January 22, 2015. The most significant proposed change is eliminating the rules on certain price representations -- the cents offintroductory offer, andeconomy size rules -- because they are no longer common in the marketplace and the Commission has other means for policing deceptive price representations. more

Fourth Question of the Day January 31, 2015 How many false and misleading claims by compounding pharmacies will we see the Federal Trade Commission Take on this year? How many compounding pharmacy websites need to clean up and remove these type of claims from their websites? Are the organizations that represent these groups advocating for compliance in this area or will they oppose any regulation by the FTC?